Clinical Trials Browser

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT04461886 2022-05-24

A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I

Phase 3 Terminated

100 enrolled

CNS

Neurofibromatoses

NCT00045968 2022-05-18

GBM

Phase 3 Unknown

348 enrolled

CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT02796261 2022-01-21

STELLAR

Phase 3 Unknown

343 enrolled

CNS

Astrocytoma, Brain Neoplasms, Glioma

NCT00005887 2021-08-23

Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases

Phase 3 Completed

CNS

Brain Neoplasms, Neoplasm Metastasis

NCT03393000 2021-07-22

INTACT

Phase 3 Terminated

19 enrolled 8 charts

CNS

Glioblastoma

NCT03419403 2021-04-14

UNITE Study: Understanding New Interventions With GBM ThErapy

Phase 3 Terminated

40 enrolled 16 charts

CNS

Glioblastoma, Neoplasms

NCT04277221 2020-03-17

ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)

Phase 3 Unknown

118 enrolled

CNS

Glioblastoma

NCT00295815 2019-09-12

Enzastaurin Versus Lomustine in Glioblastoma

Phase 3 Completed

397 enrolled

CNS

Glioblastoma

NCT04058704 2019-08-15

SMART

Phase 3 Unknown

296 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00126412 2019-05-31

Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma

Phase 3 Completed

251 enrolled

CNSEndocrine

Disease, Neuroblastoma, Pheochromocytoma

NCT00820222 2019-04-02

Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer

Phase 3 Completed

540 enrolled 18 charts

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT02511405 2018-10-23

GLOBE

Phase 3 Completed

252 enrolled

CNS

Glioblastoma

NCT01480479 2018-01-16

ACT IV

Phase 3 Completed

745 enrolled

CNSSarcoma

Brain Neoplasms, Glioblastoma, Neoplasms, Gliosarcoma

NCT00943826 2017-09-25

A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma

Phase 3 Completed

921 enrolled 14 charts

CNS

Glioblastoma

NCT00522951 2017-08-28

SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study

Phase 3 Completed

165 enrolled 24 charts

CNS

Brain Neoplasms

NCT00335075 2017-05-15

Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)

Phase 3 Completed

151 enrolled

CNS

Astrocytoma, Glioblastoma

Clinical Trials

LIMITLESS

ACTION

IPAX BrIGHT

A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas

Open-Label Study of 18F-mFBG for Imaging Neuroblastoma

KOMET

EF-41

SIGMA

BRIDGES

DESTINY-B12

GDX-44-016

SONOBIRD

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

STAR-3

REVELATE

CheckMate548

CSCRGBM

CheckMate 143

Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)

FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas

Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM

MEN-301

A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

Intellance1

ANGLeD

CheckMate 498

MERLIN

METRICS

A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I

GBM

STELLAR

Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases

INTACT

UNITE Study: Understanding New Interventions With GBM ThErapy

ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)

Enzastaurin Versus Lomustine in Glioblastoma

SMART

Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma

Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer

GLOBE

ACT IV

A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma

SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study

Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)